First Results of the Phase 3 CheckMate 9ER Trial

First Results of the Phase 3 CheckMate 9ER Trial

Episodes

Specialty:

All

Year:

All

Trending on OncLive

FDA Grants Fast Track Designation to Plinabulin Plus Docetaxel in Post-ICI Non-Squamous NSCLC

Breast Cancer Experts Highlight Abstracts to Watch at ESMO 2026

Oral Azacitidine and Cedazuridine Meets Primary Pharmacokinetic End Point in MDS and CMML

Optune Pax Is Approved in Japan for Unresectable Locally Advanced Pancreatic Cancer

UTRxMYCN M1-14 Nets FDA Dual Designations in Soft Tissue Sarcoma